On June 28, 2021, Kanagawa Prefecture governor Yuji Kuroiwa held a press conference announcing two COVID-19 technologies that have been collaboratively developed by Mirai Genomics and Kanagawa Prefecture.
The first technology is PEM reagents, reagents able to identify simultaneously the infection presence and the SARS-CoV-2 mutant strains by PCR method.
The second technology is LifePad, a cutting-edge POC solution, with 1 step to get the result with 99.9% accuracy in 40 minutes using own licensed SmartAmp® isothermal amplification technology.
Kanagawa Prefecture will continue to support these technologies that greatly contribute to the prevention of the infection spread in the prefecture.
See more here.
On July 10, 2021 Mirai Genomics took part in the 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID). ECCMID is one of the most comprehensive and influential congresses in the field and brings together more than 14,000 colleagues from all over the world.
The session of Mirai Genomics hosted Prof. Hayashizaki, CEO of Mirai Genomics and a well-established scientist known worldwide as a leading specialist in genome research and covered the best practices use for COVID-19 testing, underlining LifePad as a POC diagnostic method with a superior testing accuracy. You could watch the full version of the session here.